Quest Diagnostics Incorporated updated earnings guidance for the full year of 2024. For the year, the company expects net revenues to be between $9.40 billion to $9.48 billion, Net revenues increase to be between 1.6% to 2.5%, Reported diluted EPS to be between $7.57 to $7.82 compared to the previous guidance of net revenues to be between $9.35 billion to $9.45 billion, Net revenues increase to be between 1.1% to 2.1%, Reported diluted EPS to be between $7.69 to $7.99.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
137.9 USD | +1.28% | +0.78% | -0.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.35% | 15.12B | |
+17.21% | 81.04B | |
-30.01% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-10.94% | 16.99B | |
+5.04% | 13.09B | |
+66.71% | 12B | |
-2.88% | 11.94B | |
-31.40% | 11.92B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024